Rejected Grants May Be Sent Back for More Review
California stem cell agency chairman J.T. Thomas has raised the possibility of sending some of the disease team applications back for additional review if the board feels that is necessary to consider new information and resolve scientific disputes.
Thomas discussed such a move at the beginning of the discussion of the $243 million disease team round. N…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.